Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 1998 Jun 29;141(7):1659–1673. doi: 10.1083/jcb.141.7.1659

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Effect of anti-VEGF antibody on FGF-2–induced angiogenesis. Hydron pellets containing 50 ng of rFGF-2 with or without 1 μg of anti-VEGF monoclonal antibody were implanted in the cornea of both eyes of Swiss Webster mice as described in Materials and Methods. Each group consisted of six animals. The corneas were photographed by slit-lamp biomicroscopy on day 5 after implantation of the pellet. FGF-2 pellet: eyes that received corneal implantation of pellets containing FGF-2 alone. FGF-2/ VEGF IgG pellet: eyes that received corneal implantation of pellets containing FGF-2 and antibody to VEGF. The eyes that received corneal implants of pellets containing FGF-2 and VEGF antibody have fewer and thinner corneal limbic capillaries than eyes that received corneal implants of pellets containing FGF-2 alone.